RYR1-related disease study
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study looks at people with RYR1-related conditions like muscle weakness or malignant hyperthermia. The goal is to learn more about these conditions and how common they are.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known RYR1 gene mutation that causes disease.
- You have symptoms of a related condition, such as a congenital myopathy or malignant hyperthermia.
- You have been seen by a specialist at one of the national centers for this condition.
- You live in one of the countries taking part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks at genes and molecules to better understand congenital myopathies (birth-related muscle weakness). It may help explain the cause of symptoms and improve future diagnoses for you and your family.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This study sets up a patient registry for people diagnosed with myotubular myopathy or centronuclear myopathy. Your information can help researchers better understand these conditions and plan future studies or treatments.
This study looks at leftover muscle tissue from people who have had genetic testing for rare muscle diseases but didn't get a clear diagnosis. The goal is to use newer genetic analysis to find the cause of their disease.
This study follows people with RYR1-related disorders over time to learn how the condition progresses. It may help researchers plan future treatments.
This study creates a registry for people with rare changes in the RYR2 gene that affect heart function. Researchers will collect information to better understand these conditions and improve care.
Hear when a new Congenital Myopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.